MedPath

CANTHARIDIN 1% / PODOPHYLLUM RESIN 5% / SALICYLIC ACID 30%

CANTHARIDIN 1% / PODOPHYLLUM RESIN 5% / SALICYLIC ACID 30%

Approved
Approval ID

891a7037-9b8a-cbd3-e053-2a95a90a7006

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 17, 2019

Manufacturers
FDA

Sincerus Florida, LLC

DUNS: 080105003

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

CANTHARIDIN 1% / PODOPHYLLUM RESIN 5% / SALICYLIC ACID 30%

PRODUCT DETAILS

NDC Product Code72934-9036
Application NumberN/A
Marketing CategoryN/A
Route of AdministrationTOPICAL
Effective DateMay 17, 2019
Generic NameCANTHARIDIN 1% / PODOPHYLLUM RESIN 5% / SALICYLIC ACID 30%

INGREDIENTS (3)

SALICYLIC ACIDActive
Quantity: 30 g in 100 g
Code: O414PZ4LPZ
Classification: ACTIB
CANTHARIDINActive
Quantity: 1 g in 100 g
Code: IGL471WQ8P
Classification: ACTIB
PODOPHYLLUM RESINActive
Quantity: 5 g in 100 g
Code: 16902YVY2B
Classification: ACTIB
© Copyright 2025. All Rights Reserved by MedPath
CANTHARIDIN 1% / PODOPHYLLUM RESIN 5% / SALICYLIC ACID 30% - FDA Approval | MedPath